13.4: Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active metabolite hydromorphone-3-glucuronide. Oxycodone, granting analgesia within 5-10 minutes via parenteral dosing, offers relief for 3-4 hours. Oxycodone's abuse potential has led to misuse. Hydrocodone, a codeine derivative, boasts a 4-hour half-life. Oxymorphone, from thebaine, mirrors oxycodone in onset and duration.

Synthetic opioids include artificial analogs like meperidine, methadone, and fentanyl and its cogeners. Meperidine or pethidine causes restlessness and, combined with monoamine oxidase inhibitors, convulsions. Methadone excels in addiction and chronic pain management, peaking around 4 hours. Other drugs like tramadol and tapentadol yield mild-to-moderate pain relief, with tapentadol bearing serotonin syndrome risks alongside certain antidepressants. Buprenorphine, a μ receptor partial agonist, wields robust analgesia and fights heroin addiction. It aids addiction but triggers withdrawal if halted abruptly. Fentanyl and its analogs - alfentanil, sufentanil, and remifentanil - are potent opioids with quick onset and short durations versus morphine. Fentanyl triggers adverse effects like respiratory depression, nausea, constipation, and more. Remifentanil beats fentanyl in onset and is suited for brief procedures. Levorphanol mimics morphine's analgesic prowess. Etorphine immobilizes wild animals in veterinary settings. Meptazinol's shorter duration and fewer side effects make it ideal for obstetric analgesia. Tramadol and tapentadol excel postoperative as their side effects pale. Nalbuphine impacts κ, μ, and δ receptors with less euphoria than μ agonists. Cebranopadol acts on all four opioid receptors; loperamide curbs diarrhea and analgesia.

Semisynthetic opioids, derived from morphine, are utilized for pain management.

Their modified structures enhance their efficacy and alter the pharmacokinetic profile.

For instance, oxymorphone, oxycodone, and hydromorphone display enhanced oral bioavailability, with oxycodone additionally having a faster onset of action than morphine.

While they are effective analgesics, they have potential adverse effects, including constipation, cough, nausea, and depression.

Synthetic opioids, with unique structures, provide potent analgesic effects.

Fentanyl and its derivatives are clinically valued for their potency and rapid onset of action.

Methadone is a potent μ receptor agonist. It is useful in treating chronic pain and opioid addiction due to its long duration of action and reduced euphoria.

Although these drugs are crucial in pain and addiction management, they also show potential adverse effects, including respiratory depression and addiction.

So, careful prescribing and monitoring are essential to mitigate potential risks and ensure optimal patient well-being.